Glulisine + Lantus in Type I Patients
NCT00545337
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG:
Insuline glulisine
Sponsor
Sanofi